Targeting conserved viral virulence determinants by single domain antibodies to block SARS-CoV2 infectivity
Singh, S.; Dahiya, S.; Singh, Y. J.; Beeton, K.; Jain, A.; Sarkar, R.; Dubey, A.; Tehseen, S. A.; Sehrawat, S.
Show abstract
We selected SARS-CoV2 specific single domain antibodies (sdAbs) from a previously constructed phage display library using synthetic immunogenic peptides of the virus spike (S) protein as bait. The sdAbs targeting the cleavage site (CS) and the receptor binding domain (RBD) in S protein efficiently neutralised the infectivity of a pseudovirus expressing SARS-CoV2 S protein. Anti-CS sdAb blocked the virus infectivity by inhibiting proteolytic processing of SARS-CoV2 S protein. Both the sdAbs retained characteristic structure within the pH range of 2 to 12 and remained stable upto 65{degrees}C. Furthermore, structural disruptions induced by a high temperature in both the sdAbs were largely reversed upon their gradual cooling and the resulting products neutralised the reporter virus. Our results therefore suggest that targeting CS in addition to the RBD of S protein by sdAbs could serve as a viable option to reduce SARS-CoV2 infectivity and that proteolytic processing of the viral S protein is critical for infection.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals 96%
- Nasal delivery of single-domain antibodies improve symptoms of SARS-CoV-2 infection in an animal model 96%
- Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site 95%
Similar papers in this journal
- A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants 95%
- Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2 94%
- Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without 94%
Similar papers in this journal
- A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern 96%
- Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases 95%
- Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity and neutralization sensitivity 95%
Similar papers in this journal
- RG203KR mutations in SARS-CoV-2 Nucleocapsid: Assessing the impact using Virus-like particle model system 96%
- Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunity 93%
- Analysis of the Role of N-glycosylation in Cell-surface expression, Function and Binding Properties of SARS-CoV-2 receptor ACE2 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.